Kymera Therapeutics, Inc. Share Price
KYMRKymera Therapeutics, Inc. Stock Performance
Open $84.44 | Prev. Close $81.98 | Circuit Range N/A |
Day Range $78.02 - $84.44 | Year Range $28.06 - $102.81 | Volume 54,049 |
Average Traded $79.37 |
Kymera Therapeutics, Inc. Share Price Chart
About Kymera Therapeutics, Inc.
Kymera Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on discovering and developing small molecule therapeutics that selectively degrade disease-causing proteins by harnessing the body's own natural protein degradation system. It engages in developing IRAK4 program, which is in Phase II clinical trial for the treatment of immunology-inflammation diseases, including hidradenitis suppurativa and atopic dermatitis. The company also develops STAT6, a type 2 inflammation in allergic and atopic diseases; and TYK2 to treat autoimmune and inflammatory diseases. The company has a strategic alliance with Sanofi S.A. for the development of drug candidates targeting IRAK4 outside of the oncology and immuno-oncology fields. Kymera Therapeutics, Inc. was incorporated in 2015 and is headquartered in Watertown, Massachusetts.
Kymera Therapeutics, Inc. Historical Data
| Day | Open | Close | Change % |
|---|---|---|---|
30-Apr-26 | $84.44 | $81.07 | +0.00% |
30-Apr-26 | $84.44 | $81.07 | -0.59% |
29-Apr-26 | $83.07 | $81.55 | -2.68% |
28-Apr-26 | $87.23 | $83.80 | -3.34% |
27-Apr-26 | $86.56 | $86.70 | +2.16% |
24-Apr-26 | $86.00 | $84.87 | -2.65% |
23-Apr-26 | $88.97 | $87.18 | -1.77% |
FAQs on Kymera Therapeutics, Inc. Share Price
Can I buy Kymera Therapeutics, Inc. shares in India?
What is the share price of Kymera Therapeutics, Inc.?
What is the 5 year returns of Kymera Therapeutics, Inc.?
What are the high & low stock price of Kymera Therapeutics, Inc. today?
What is the 52-week high and low of Kymera Therapeutics, Inc. stock?